Asian Insider

India's Covid-19 vaccine manufacturing prowess drives new Quad initiative

No consensus is emerging in European capitals about how Europe should interact with the Quad. PHOTO: AFP
Gift this subscriber-only story to your friends and family

NEW DELHI - India's pharmaceutical capacity is at the centre of a Quad initiative to deliver one billion Covid-19 vaccine doses by the end of next year.

Officials from the four Quad members - Australia, India, Japan and the United States - are now working out the fine details of the so-called Quad Vaccine Partnership which could potentially cover the vaccination of nearly everyone in Asia besides those in its two most populous countries - China and India.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.